Cargando…

Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer

Ovarian cancers exhibit high rates of recurrence and poor treatment response. Preclinical models that recapitulate human disease are critical to develop new therapeutic approaches. Syngeneic mouse models allow for the generation of tumours comprising the full repertoire of non-malignant cell types b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cook, David P., Galpin, Kristianne J. C., Rodriguez, Galaxia M., Shakfa, Noor, Wilson-Sanchez, Juliette, Echaibi, Maryam, Pereira, Madison, Matuszewska, Kathy, Haagsma, Jacob, Murshed, Humaira, Cudmore, Alison O., MacDonald, Elizabeth, Tone, Alicia, Shepherd, Trevor G., Petrik, James J., Koti, Madhuri, Vanderhyden, Barbara C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643551/ https://www.ncbi.nlm.nih.gov/pubmed/37957414 http://dx.doi.org/10.1038/s42003-023-05529-z

Ejemplares similares

BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy
por: Farokhi Boroujeni, Salar, et al.
Publicado: (2023)

LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model
por: Mehdi, Sadia, et al.
Publicado: (2020)

The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
por: Rodriguez, Galaxia M., et al.
Publicado: (2018)

Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
por: McCloskey, Curtis W., et al.
Publicado: (2018)

The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool for Ovarian Cancer Immunotherapy Research
por: Rodriguez, Galaxia M., et al.
Publicado: (2022)

Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo
por: Pereira, Madison, et al.
Publicado: (2023)

Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer
por: Shakfa, Noor, et al.
Publicado: (2023)

A New Spontaneously Transformed Syngeneic Model of High-Grade Serous Ovarian Cancer with a Tumor-Initiating Cell Population
por: McCloskey, Curtis W., et al.
Publicado: (2014)

Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake
por: Matuszewska, Kathy, et al.
Publicado: (2021)

Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer
por: Pereira, Madison, et al.
Publicado: (2021)

Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy
por: Pereira, Madison, et al.
Publicado: (2022)

Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer
por: Greenaway, James B., et al.
Publicado: (2016)

Gene networks and expression quantitative trait loci associated with adjuvant chemotherapy response in high-grade serous ovarian cancer
por: Choi, Jihoon, et al.
Publicado: (2020)

Intra-Tumoral Nerve-Tracing in a Novel Syngeneic Model of High-Grade Serous Ovarian Carcinoma
por: Barr, Jeffrey L., et al.
Publicado: (2021)

STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer
por: Ghaffari, Abdi, et al.
Publicado: (2018)

Quantitative and Semi-quantitative Methods for Assessing the Degree of Methylene Blue Staining in Sentinel Lymph Nodes in Dogs
por: Ram, Ann S., et al.
Publicado: (2021)

Liposomal delivery of gene therapy for ovarian cancer: a systematic review
por: Son, Jin Sung, et al.
Publicado: (2023)

Gain-of-function p53(R175H) blocks apoptosis in a precursor model of ovarian high-grade serous carcinoma
por: Haagsma, Jacob, et al.
Publicado: (2023)

Conventional DNA-Damaging Cancer Therapies and Emerging cGAS-STING Activation: A Review and Perspectives Regarding Immunotherapeutic Potential
por: Lewicky, Jordan D., et al.
Publicado: (2023)

Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment
por: Wallace-Povirk, Adrianne, et al.
Publicado: (2022)

Ly phenotype of cytotoxic T cells for syngeneic tumor
Publicado: (1976)

Syngeneic leukemia models using lentiviral transgenics
por: Keinan, Nurit, et al.
Publicado: (2021)

l-Arginine stimulates intestinal intraepithelial lymphocyte functions and immune response in chickens orally immunized with live intermediate plus strain of infectious bursal disease vaccine
por: Tayade, Chandrakant, et al.
Publicado: (2006)

STAT1‐associated intratumoural T(H)1 immunity predicts chemotherapy resistance in high‐grade serous ovarian cancer
por: Au, Katrina K, et al.
Publicado: (2016)

Growth of Syngeneic Tumours in Unimmunized Newborn and Adult Hosts
por: Forni, G., et al.
Publicado: (1973)

Immunization with HIV protease peptides linked to syngeneic erythrocytes
por: Boberg, Andreas, et al.
Publicado: (2007)

THE CYTOTOXIC EFFECT OF MOUSE MACROPHAGES ON SYNGENEIC AND ALLOGENEIC ERYTHROCYTES
por: Melsom, H., et al.
Publicado: (1973)

Concanavalin A potentiates syngeneic response in murine lymphocytes
Publicado: (1976)

Regulation of cytotoxic T-cell reactivity to syngeneic tumors by the thymus
Publicado: (1978)

Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes
Publicado: (1980)

Optimization of a syngeneic murine model of bone metastasis
por: Farhoodi, Henry P., et al.
Publicado: (2020)

Selective, high-contrast detection of syngeneic glioblastoma in vivo
por: Banati, Richard B., et al.
Publicado: (2020)

Molecular Mechanisms in Murine Syngeneic Leukemia Stem Cells
por: Chamo, Michael, et al.
Publicado: (2023)

Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis
por: Black, Madison, et al.
Publicado: (2016)

Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer
por: Koti, Madhuri, et al.
Publicado: (2013)

Primary vaginal adenocarcinoma of intestinal type or occult metastatic colon cancer: a diagnostic dilemma from a vaginal skin tag
por: Russell, Anna Louise, et al.
Publicado: (2019)

The Tumor Immune Contexture of Prostate Cancer
por: Vitkin, Natasha, et al.
Publicado: (2019)

Response of Syngeneic Murine Lymphomata to Immunotherapy in Relation to the Antigencity of the Tumour
por: Parr, Iris
Publicado: (1972)

Promotion of fibrosarcoma cell growth by products of syngeneic host macrophages.
por: Currie, G. A.
Publicado: (1981)

Non-immunogenicity of enucleated rat hepatoma cells in syngeneic animals.
por: Gerlier, D., et al.
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_744e76ok9qna0ncpppu0ugrrli